ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 12, No. 5, May 2025 | pp. 243–253
DOI: 10.46882/AJIDR/148772
Article Type: Research Article
Title: Seroprevalence and risk factors of Hepatitis B and Hepatitis D virus co-infection among chronic liver disease patients
Names of Authors: Moussa Diallo¹*, Katarina Horvat²
Authors’ Affiliations: ¹Department of Gastroenterology, Cheikh Anta Diop University, Dakar, Senegal. ²Department of Infectious Diseases, University of Zagreb, Zagreb, Croatia.
Abstract: Hepatitis D virus superinfection accelerates progression to cirrhosis and hepatocellular carcinoma in individuals with chronic Hepatitis B virus infection. We evaluated the seroprevalence, viremia rates, and clinical correlates of Hepatitis D virus among Hepatitis B surface antigen-positive patients. Serum samples from 275 patients with chronic Hepatitis B were tested for anti-HDV antibodies by enzyme-linked immunosorbent assay and quantitative HDV RNA via real-time reverse transcription polymerase chain reaction. Anti-HDV antibodies were detected in 13.8 percent of patients, with active HDV RNA viremia confirmed in 71.1 percent of seropositive cases. Co-infected patients exhibited significantly higher liver stiffness scores and elevated transaminase levels. Universal reflex anti-HDV testing is recommended for all Hepatitis B carriers.
Keywords: Hepatitis D virus, Hepatitis B co-infection, Chronic liver disease, Cirrhosis, Viral hepatitis
Citation: Diallo M, Horvat K (2025). Seroprevalence and risk factors of Hepatitis B and Hepatitis D virus co-infection among chronic liver disease patients. African Journal of Infectious Diseases Research, 12(5): 243–253. DOI: 10.46882/AJIDR/148772
Manuscript Timeline: Received: March 19, 2025; Revised: April 20, 2025; Accepted: May 03, 2025; Published: May 10, 2025
Subscribe to read the full article: https://mail.internationalscholarsjournals.org/subscribe-to-read